TP53 and ovarian carcinoma: We could conclude therefore that the inhibition of ovarian carcinoma cell proliferation arose mainly from the combination effect of p53/p21-mediated G1 phase arrest of the cell cycle and Bax/Bcl-2 ratio/caspase-3-induced apoptotic death.